Pfizer und BioNTech beginnen klinische Studie zu Omikron-basiertem COVID-19-Impfstoff bei Erwachsenen im Alter von 18-55 Jahren
January 25, 2022 06:45 ET
|
BioNTech SE
Die ersten Teilnehmer erhielten im Rahmen der klinischen Studie den Omikron-basierten Impfstoffkandidaten als Impfserie mit zwei Dosen oder als Auffrischungsimpfung NEW YORK und MAINZ, Deutschland,...
BioNTech und InstaDeep entwickeln und testen erfolgreich ein Frühwarnsystem zur Erkennung potenzieller Hochrisikovarianten von SARS-CoV-2
January 11, 2022 07:00 ET
|
BioNTech SE
Das Frühwarnsystem kombiniert Strukturmodellierung von Spike-Proteinen mit künstlicher Intelligenz (KI), um Hochrisikovarianten von SARS-CoV-2 zu erkennen und zu überwachen; dabei können...
BioNTech and InstaDeep Developed and Successfully Tested Early Warning System to Detect Potential High-Risk SARS-CoV-2 Variants
January 11, 2022 07:00 ET
|
BioNTech SE
Early Warning System combines Spike protein structural modeling with artificial intelligence (AI) to detect and monitor high-risk SARS-CoV-2 variants, identifying >90% of WHO-designated variants on...
Dyadic Announces a NIIMBL Coronavirus Grant Under the White House’s American Rescue Plan
December 22, 2021 09:12 ET
|
Dyadic International, Inc.
JUPITER, Fla., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
SAB Biotherapeutics Announces SAB-185 Retains Neutralization Against Omicron SARS-CoV-2 Variant In Vitro
December 16, 2021 06:00 ET
|
SAB Biotherapeutics, Inc.
FDA laboratory testing confirms SAB-185 neutralizes Omicronand other variants of concern with in vitro pseudovirus model SAB’s targeted, highly potent and fully-human polyclonal antibodies continue...
Cobalt Connects with Dealers to Celebrate a Successful Year and Introduce the New R4 Series with its Three All-New Variants
September 24, 2021 10:00 ET
|
Cobalt Boats
NEODESHA, Kan., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Premium luxury manufacturer Cobalt Boats resumed its series of popular World Class Dealer Network annual celebrations this year with a three-day...
Codex DNA Releases Full-Length Synthetic Genome for Highly Infectious SARS-CoV-2 Delta Variant
September 01, 2021 16:15 ET
|
Codex
San Diego, CA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of its first full-length...
MAKO Medical Forges Partnership with the CDC
May 13, 2021 13:58 ET
|
MAKO Medical
Raleigh, North Carolina, May 13, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced a comprehensive partnership with...
Dyadic to Present at Upcoming Events
May 03, 2021 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., May 03, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI) a global biotechnology company focused on further improving, applying and...
Dyadic International Hosting a Fireside Chat on “The Potential of the Transformative Dyadic C1 Protein Technology in Helping Meet Global Health Challenges”
April 22, 2021 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on developing and...